Work

Abstract PO-007: The Class I/IV HDAC Inhibitor Mocetinostat Augments Anti-Tumor Immune Responses in Melanoma Patients

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.epimetab20-po-007

Authors: David M. Woods, Andressa S. Laino, Melinda Vassallo, Jeffrey Weber

Institutions: University of Colorado Anschutz, Moderna Therapeutics (United States), NYU Langone Health

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3107461333

Cites:

Cited by: 2

Related to: 10